Incannex Healthcare Limited
IXHLNASDAQHealthcare● Active
$3.40
+$0.48(+16.44%)
Market Cap$39048170
P/E Ratio—
52W High$49.8
52W Low$2.49
Incannex Healthcare Limited (IXHL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IXHL · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.09M | $0.01M | $0.00M | $0.79M | $1.90M |
| Cost of Revenue | $0.25M | $0.10M | $0.00M | $0.01M | $0.91M |
| Gross Profit | ($0.16M) | $0.01M | $0.00M | $0.78M | $0.99M |
| Gross Margin %(computed) | -186.05% | 100.00% | — | 99.19% | 51.94% |
| Operating Expenses | |||||
| R&D Expenses | $10.75M | $19.28M | $9.50M | $5.37M | $4.76M |
| G&A Expenses | $12.74M | $23.98M | $10.05M | $7.43M | $3.34M |
| Total Operating Expenses | $23.63M | $30.05M | $20.53M | $10.16M | $12.41M |
| Operating Income | ($23.79M) | ($30.04M) | ($20.53M) | ($10.16M) | ($11.43M) |
| Operating Margin %(computed) | — | — | — | — | -601.34% |
| Interest Income | $0.06M | $0.31M | $0.36M | $0.01M | $0.00M |
| Interest Expense | $0.30M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($48.64M) | ($18.43M) | ($73.47M) | ($10.25M) | ($11.39M) |
| Income Tax Expense | ($1.76M) | $0.03M | $0.00M | $0.00M | $0.00M |
| Net Income | ($46.88M) | ($18.46M) | ($73.47M) | ($14.90M) | ($11.39M) |
| Net Margin %(computed) | — | — | — | — | -599.33% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-40.80 | $-3.42 | $-14.31 | $-1.51 | $-1.40 |
| Wtd Avg Shares | 1.15M | 5.39M | 5.13M | 9.93M | 8.15M |
| EBITDA | ($23.54M) | ($27.70M) | ($20.39M) | ($16.54M) | ($11.43M) |
| EBITDA Margin %(computed) | — | — | — | — | -601.34% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Incannex Healthcare Limited data
About Incannex Healthcare Limited (IXHL) Income Statement
Incannex Healthcare Limited (IXHL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IXHL reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -186.05%), and net income of ($0.05B) — a net profit margin of -54517.44%.
Frequently asked questions
IXHL · 4 questionsIncannex Healthcare Limited (IXHL) reported revenue of $0.00B for 2025, up 616.7% year-over-year.
IXHL revenueIXHL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08